MMS22L是正常和病理性红色素形成的一个新型关键参与者
Elia Colin1,2, Ivan Ferrer-Vicens3, Dror Brook4
1Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, INSERM UMR_S 1163, Imagine Institute Université Paris Cité Paris France.
HemaSphere
|December 25, 2025
概括
研究人员发现了一种新基因,MMS22L,对于红细胞形成 (红细胞生成) 至关重要. 在MMS22L和CDAN1的突变导致严重的贫血,提供了对先天性缺血性贫血1型 (CDAI) 的新见解.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 通过下一代测序,人们越来越了解先天性红状腺疾病.
- CDAN1基因与1型先天性失血性贫血 (CDAI) 有关.
研究的目的:
- 为了对患有非典型的先天性纯红细胞无形成症的患者进行遗传特征.
- 研究新型基因突变在红色素形成和CDAI病理生理学中的作用.
主要方法:
- 在一个患有非典型的先天性纯红细胞无形成症的患者身上进行了整个外体序列测序.
- 斑马鱼模型被用来研究mms22l和cdan1的合并效应.
- 分析了人类红色素原体,以了解MMS22L损失的功能影响.
主要成果:
- 一名患者在CDAN1中出现突变,在MMS22L中出现新突变.
- 结合mms22l和cdan1的哈普洛缺陷导致斑马鱼的严重贫血.
- 人类红色素原体中MMS22L的丧失导致了增殖停止,p53通路激活和表观遗传变化.
- MMS22L和CDAN1形成了一个蛋白质复合体,其核进口由IPO4.4介导.
- 在CDAI患者中,MMS22L核进口因CDAN1-IPO4相互作用缺陷而受损.
结论:
- MMS22L被确定为新型的,不可或缺的因素在红色素形成.
- 对mms22l和cdan1突变的基因遗传导致严重的贫血.
- 这项研究提供了对红色受体调节和CDAI病理生理学的新见解,突出了MMS22L-CDAN1-IPO4复合体.
更多相关视频
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
870
06:40Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
Published on: September 9, 2014
15.7K
相关概念视频
01:14Erythropoiesis
5.6K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.6K
01:28Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
01:24Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
01:27Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
01:20Overview of Hematopoiesis
8.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.1K
01:21Hematopoiesis
8.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.5K